Open Search
Close Search
Full Committee Hearing

Drug Pricing in America: A Prescription for Change, Part III

Date: 
Time: 
Location:  215 Dirksen Senate Office Building

Meeting Agenda

Member Statements

  1. Chuck Grassley

    R - IA

  2. Ron Wyden

    D - OR

Witnesses

  1. Steve Miller, MD

    Executive Vice President and Chief Clinical Officer
    Cigna Corporation
    Bloomfield, CT
    Download Testimony

  2. Derica Rice

    Executive Vice President and President
    CVS Health and CVS Caremark
    Woonsocket, RI
    Download Testimony

  3. William Fleming, Pharm.D.

    Segment President, Healthcare Services
    Humana Inc.
    Louisville, KY
    Download Testimony

  4. John Prince

    Chief Executive Officer
    OptumRx
    Minnetonka, MN
    Download Testimony

  5. Mike Kolar, JD

    Interim President & CEO, Senior Vice President and General Counsel
    Prime Therapeutics LLC
    Eagan, MN
    Download Testimony

Related Files

  1. Drug Pricing in America: A Prescription for Change, Part III

    Download File
Print 
Email 
Share 
Share 

How do I submit a statement for the record?

Any individual or organization wanting to present their views for inclusion in the hearing record should submit in a Word document, a single-spaced statement, not exceeding 10 pages in length. No other file type will be accepted for inclusion. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing. Non-compliant submissions will not be accepted. Submissions are not reviewed by policy staff.

Statements can be emailed to:

Statementsfortherecord@finance.senate.gov

Statements can be mailed (not faxed) to:

Senate Committee on Finance
Attn. Editorial and Document Section
Rm. SD-219
Dirksen Senate Office Bldg.
Washington, DC 20510-6200